Skip to search formSkip to main contentSkip to account menu

T 3761

Known as: T-3761 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
T-3762 is an injectable new quinolone with a broad spectrum of antibacterial activity. Pazufloxacin (T-3761) is an active form of… 
1995
1995
The mechanism of the renal excretion of T-3761, a novel oral fluoroquinolone agent, was studied by renal clearance, stop-flow… 
1995
1995
The structures of light degradation products of (-)-(S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dih ydr o-7H- pyrido… 
1995
1995
Phototoxicity and photoallergenicity tests of T-3761 (oral or percutaneous administration) were carried out in guinea pigs… 
1995
1995
The affinity of T-3761 to melanin was examined with synthetic melanin comparing other quinolones. The binding rates with… 
1995
1995
We studied the absorption, distribution, metabolism and excretion of T-3761, a new quinolone derivative, in experimental animals… 
1995
1995
Absorption, distribution, excretion and metabolism were studied in rats and mice after oral and intravenous administration of 5… 
1995
1995
A microbiological assay method for measurement of T-3761 and its stability in body fluids were investigated. The paper disc… 
1995
1995
We investigated the extent of the binding of T-3761 to serum protein and obtained the following results. 1. The binding rates of… 
1993
1993
We evaluated the in vitro antimicrobial activity of NM394 and ofloxacin (OFLX) against representative pathogenic mycobacteria by…